CRL - CIK 0001100682
The table below shows CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $737.65M | $734.58M | $683.90M | $619.64M | $760.80M | $546.58M |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | -$209.32M | -$245.09M | -$563.15M | -$607.92M | -$1.44B | -$601.54M |
| Dividends paid | - | - | - | - | - | - |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported operating cash flow of $737.65M for fiscal year 2025. That is up 0.4% from $734.58M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $316.90M (FY 2016) to $737.65M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | $360.67M | $119.17M | $24.16M | $38.65M | $40.71M | $23.98M |
| Financing cash flow | -$536.73M | -$550.93M | -$85.52M | -$42.40M | $672.60M | $47.25M |